SAVE Moms and Babies Act of 2025
Representative Latta Proposes Bill to Ban New Abortion Drugs and Require In-Person Doctor Visits
Stalled
No legislative action in over 90 days.
Legislative Progress
Key Points
- This bill would stop the FDA from approving any new drugs used for abortions and would end ongoing medical research into new abortion medications after three years.
- For drugs already on the market, the bill bans mail-order delivery and pharmacy pickups, requiring patients to get the medicine in person from a doctor at a clinic, medical office, or hospital.
- Doctors who prescribe these drugs would need special certification and must be able to perform surgery or provide blood transfusions if a patient has a serious medical emergency.
- The policy limits the use of these drugs to the first 70 days of pregnancy and prevents the government from ever extending that time limit or loosening the rules for how they are given to patients.
- Manufacturers and healthcare providers would be required to report all serious complications, hospitalizations, and deaths related to the drugs to the FDA to monitor safety.
Impact Analysis
Personal Impact
Life & Work
This bill would dramatically restrict access to medication abortion (mifepristone) for pregnant individuals seeking to end a pregnancy. It bans mail-order and pharmacy dispensing, requiring in-person visits to a certified doctor at a clinic, medical office, or hospital. It also freezes the gestational limit at 70 days and prohibits any future loosening of these rules. For the roughly 500,000+ people per year who use medication abortion, this creates significant new barriers including travel, cost, and time burdens — especially in rural areas or states with few providers.
Programs
Disabilities
Milestones
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
5 articlesNew Bill: Representative Robert E. Latta introduces H.R. 685: Support And Value Expectant Moms and Babies Act of 2025
The bill prohibits the approval of new abortion drugs by the HHS Secretary and prevents investigational use exemptions for drugs in research phases. For existing drugs, it bans pharmacy dispensing and mail-order delivery, requiring in-person administration by a certified healthcare practitioner.
Additional Licensure Pathways Bill Meets Resistance
The SAVE Moms and Babies Act of 2025 (H.R. 685), introduced by Rep. Bob Latta, would prohibit the approval of new abortion drugs and label changes to existing medications. It requires administration in an office setting and imposes strict reporting requirements on adverse effects.
Hyde-Smith Bill Targets Medication Abortions with 'SAVE Moms and Babies Act'
Senator Cindy Hyde-Smith reintroduced the SAVE Moms and Babies Act to prevent the FDA from lifting regulations on abortion medication. The bill aims to block mail-order distribution and telemedicine prescriptions, while critics argue it ignores data showing serious complications are rare.
Source Information
Document Type
Congressional Bill
Official Title
SAVE Moms and Babies Act of 2025
Data Sources
Sponsor
Cosponsors
(29)Analysis generated by AI. Always verify with official sources.